Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-742X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population ; day:28 ; month:3 ; year:2019 ; pages:1-10
Journal of thrombosis and thrombolysis ; (28.3.2019), 1-10
- Creator
-
Amin, Alpesh
Keshishian, Allison
Dina, Oluwaseyi
Dhamane, Amol
Nadkarni, Anagha
Carda, Eric
Russ, Cristina
Rosenblatt, Lisa
Mardekian, Jack
Yuce, Huseyin
Baker, Christine L.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11239-019-01838-5
- URN
-
urn:nbn:de:101:1-2019041920364198736710
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Amin, Alpesh
- Keshishian, Allison
- Dina, Oluwaseyi
- Dhamane, Amol
- Nadkarni, Anagha
- Carda, Eric
- Russ, Cristina
- Rosenblatt, Lisa
- Mardekian, Jack
- Yuce, Huseyin
- Baker, Christine L.
- SpringerLink (Online service)
Other Objects (12)
Effectiveness and safety in non-valvular atrial fibrillation patients switching from warfarin to direct oral anticoagulants in US healthcare claims
Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
Implementing hospital guidelines improves warfarin use in non-valvular atrial fibrillation: a before-after study
Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation
Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population
Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation
Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation
Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity
Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
Unmet Clinical Needs in Elderly Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation
Clinical factors associated with safety and efficacy in patients receiving direct oral anticoagulants for non-valvular atrial fibrillation
Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation
Effectiveness and safety in non-valvular atrial fibrillation patients switching from warfarin to direct oral anticoagulants in US healthcare claims
Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
Implementing hospital guidelines improves warfarin use in non-valvular atrial fibrillation: a before-after study
Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation
Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population
Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation
Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation
Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity
Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
Unmet Clinical Needs in Elderly Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation
Clinical factors associated with safety and efficacy in patients receiving direct oral anticoagulants for non-valvular atrial fibrillation
Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation
Effectiveness and safety in non-valvular atrial fibrillation patients switching from warfarin to direct oral anticoagulants in US healthcare claims
Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
Implementing hospital guidelines improves warfarin use in non-valvular atrial fibrillation: a before-after study
Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation
Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population
Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation
Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation
Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity
Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
Unmet Clinical Needs in Elderly Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation
Clinical factors associated with safety and efficacy in patients receiving direct oral anticoagulants for non-valvular atrial fibrillation